相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Probiotics: insights and new opportunities for Clostridioides difficile intervention
Rusha Pal et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2023)
First oral fecal microbiota transplant therapy approved
Thiago Carvalho
NATURE MEDICINE (2023)
Targeting Clostridioides difficile: New uses for old drugs
Jianwei Chen et al.
DRUG DISCOVERY TODAY (2022)
Basis of narrow-spectrum activity of fidaxomicin on Clostridioides difficile
Xinyun Cao et al.
NATURE (2022)
Discovery of a novel natural product inhibitor of Clostridioides difficile with potent activity in vitro and in vivo
Rusha Pal et al.
PLOS ONE (2022)
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
Joffrey van Prehn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro
Rusha Pal et al.
SCIENTIFIC REPORTS (2021)
Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections
Nader S. Abutaleb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Screening of Natural Products and Approved Oncology Drug Libraries for Activity against Clostridioides difficile
Rusha Pal et al.
SCIENTIFIC REPORTS (2020)
Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection
Ahmed AbdelKhalek et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI
Megan Garland et al.
CELL REPORTS MEDICINE (2020)
Antibacterial and antivirulence activities of auranofin against Clostridium difficile
Ahmed AbdelKhalek et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Efficacy and Safety of AM-111 in the Treatment of Acute Unilateral Sudden Deafness-A Double-blind, Randomized, Placebo-controlled Phase 3 Study
Hinrich Staecker et al.
OTOLOGY & NEUROTOLOGY (2019)
The future of faecal transplants
Edward M. Giles et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection
Yogitha N. Srikhanta et al.
NATURE MICROBIOLOGY (2019)
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Novel Peptide Nucleic Acid against the Cytidine Monophosphate Kinase of S. aureus Inhibits Staphylococcal Infection In Vivo
Hyung Tae Lee et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Clostridium difficile colitis: pathogenesis and host defence
Michael C. Abt et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Targeting Multidrug-resistant Staphylococci with an anti-rpoA Peptide Nucleic Acid Conjugated to the HIV-1 TAT Cell Penetrating Peptide
Mostafa F. N. Abushahba et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Clostridium difficile infection
Wiep Klaas Smits et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens
Mostafa F. N. Abushahba et al.
SCIENTIFIC REPORTS (2016)
Subconjunctival Injection of XG-102, a JNK Inhibitor Peptide, in Patients with Intraocular Inflammation: A Safety and Tolerability Study
Talal Beydoun et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant Staphylococci
Haroon Mohammad et al.
JOURNAL OF ANTIBIOTICS (2015)
Peptide nucleic acids inhibit growth of Brucella suis in pure culture and in infected murine macrophages
Parthiban Rajasekaran et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Fidaxomicin inhibits toxin production in Clostridium difficile
Farah Babakhani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
NON-CODING RNA Gene regulation by antisense transcription
Vicent Pelechano et al.
NATURE REVIEWS GENETICS (2013)
Targeting Listeria Monocytogenes rpoA and rpoD Genes Using Peptide Nucleic Acids
Ruba A. Alajlouni et al.
NUCLEIC ACID THERAPEUTICS (2013)
Inhibition of Growth and Gene Expression by PNA-peptide Conjugates in Streptococcus pyogenes
Nadja Patenge et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Targeting Essential Genes in Salmonella enterica Serovar Typhimurium with Antisense Peptide Nucleic Acid
Muhammad A. Soofi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Fidaxomicin Inhibits Spore Production in Clostridium difficile
Farah Babakhani et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis
Irina Artsimovitch et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Fecal microbiota transplantation and emerging applications
Thomas J. Borody et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis
Kirstin Reinecke et al.
PLOS ONE (2012)
Targeting RNA Polymerase Primary σ70 as a Therapeutic Strategy against Methicillin-Resistant Staphylococcus aureus by Antisense Peptide Nucleic Acid
Hui Bai et al.
PLOS ONE (2012)
Clostridium difficile infection Toxins and non-toxin virulence factors, and their contributions to disease establishment and host response
Gayatri Vedantam et al.
GUT MICROBES (2012)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Molecular Evolution of Multisubunit RNA Polymerases: Structural Analysis
William J. Lane et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
The role of toxin A and toxin B in Clostridium difficile infection
Sarah A. Kuehne et al.
NATURE (2010)
Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin Production
Sarah Underwood et al.
JOURNAL OF BACTERIOLOGY (2009)
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
Louise Caroe Vohlander Rasmussen et al.
MICROBIAL CELL FACTORIES (2007)
Peptide nucleic acid (PNA) binding-mediated gene regulation
G Wang et al.
CELL RESEARCH (2004)
The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli
R Dryselius et al.
OLIGONUCLEOTIDES (2003)
Bactericidal antisense effects of peptide-PNA conjugates
L Good et al.
NATURE BIOTECHNOLOGY (2001)